检索结果-南通市图书馆

Clinical Evidence on the Effects of Saffron(Crocus Sativus L.)in Anxiety and Depression

World Journal of Traditional Chinese Medicine 2022年第2期8卷 181-187页

作者： Vanktesh Kumar Navjot Kaur Pankaj Wadhwa Department of Pharmaceutical Chemistry School of Pharmaceutical ScienceLovely Professional UniversityPhagwaraPunjabIndia

Crocus sativus L.,a member of the Iridaceae family,commonly known as saffron has very much popular as both medicine and spice.Earlier saffron was used as one of the important constituents in opioid preparations for pain relief.Its uses in the treatment of mild-to-moderate depression are well documented.Depression can affect the quality of life of individuals by causing headaches,difficulty in thinking,and loss of interest.Many clinical trials have been conducted for evaluating the efficacy of saffron in depression cases.Almost fifty constituents of C.sativus L are well known.Few of the major constituents include crocin,picrocrocin,and safranal.In the present review,the main focus is on the antidepressant effects of saffron and its major constituents,in which it was found that saffron has substantial effects on depression and anxiety because of double-blind study the data can be trusted.

关键词： Anxiety Crocus sativus L depression double blind saffron safranin

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Efficacy and safety of Shenyankangfu Tablet,a Chinese patent medicine,for primary glomerulonephritis:A multicenter randomized controlled trial

引用

Journal of Integrative Medicine 2021年第2期19卷 111-119页

作者： Jie Wu Shu-wei Duan Hong-tao Yang Yue-yi Deng Wei Li Ya-ni He Zhao-hui Ni Yong-li Zhan Shan Lin Zhi-yong Guo Jun Zhu Jing-ai Fang Xu-sheng Liu Li-hua Wang Rong Wang Nian-song Wang Xiao-hong Cheng Li-qun He Ping Luo Shi-ren Sun Ji-feng Sun Ai-ping Yin Geng-ru Jiang Hong-yu Chen Wen-hu Liu Hong-li Lin Meng Liang Lu Ma Ming Chen Li-qun Song Jian Chen Qing Zhu Chang-ying Xing Yun Li Ji-ning Gao Rong-shan Li Ying Li Hao Zhang Ying Lu Qiao-ling Zhou Jun-zhou Fu Qiang He Guang-yan Cai Xiang-mei Chen Department of Nephrology Chinese People’s Liberation Army General HospitalChinese People’s Liberation Army Institute of NephrologyState Key Laboratory of Kidney Diseases(2011DAV00088)National Clinical Research Center for Kidney DiseasesBeijing 100853China Department of Nephrology First Teaching Hospital of Tianjin University of Traditional Chinese MedicineTianjin 300192China Department of Nephrology Longhua HospitalShanghai University of Traditional Chinese MedicineShanghai 200032China Department of Nephrology Shandong University of Traditional Chinese Medicine Affiliated HospitalJinan 250011.Shandong ProvinceChina Department of Nephrology Daping HospitalArmy Medical UniversityChongqing 400042China Department of Nephrology Renji HospitalShanghai Jiao Tong UniversityShanghai 200127China Department of Nephrology Guang’anmen HospitalChina Academy of Traditional Chinese Medical SciencesBeijing 100053China Department of Nephrology Tianjin Medical University General HospitalTianjin 300052China Department of Nephrology Changhai Hospital of ShanghaiNaval Medical UniversityShanghai 200433China Department of Nephrology West China HospitalChengdu 610083Sichuan ProvinceChina Department of Nephrology First Affiliated Hospital of Shanxi Medical UniversityTaiyuan 030001Shanxi ProvinceChina Department of Nephrology Guangdong Provincial Hospital of Chinese MedicineGuangzhou 510120Guangdong ProvinceChina Department of Nephrology Shanxi Medical University Second Affiliated HospitalTaiyuan 030001Shanxi ProvinceChina Department of Nephrology Shandong Provincial HospitalJinan 250021Shandong ProvinceChina Department of Nephrology and Rheumatology Affiliated Sixth People’s HospitalShanghai Jiao Tong UniversityShanghai 200233China Department of Nephrology Shaanxi Traditional Chinese Medicine HospitalXi'an 710003Shaanxi ProvinceChina Department of Nephrology Shuguang HospitalShanghai University of Traditional Chinese MedicineShanghai 200021China Department of Nephrology Jilin University Se

Background:Shenyankangfu Tablet(SYKFT)is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.Objective:This trial compared the efficacy and safety of SYKFT,for the control of proteinuria in primary glomerulonephritis patients,against the standard drug,losartan potassium.Design,setting,participants and intervention:This was a multicenter,double-blind,randomized,controlled clinical trial.Primary glomerulonephritis patients,aged 18-70 years,with blood pressure≤140/90 mmHg,estimated glomerular filtration rate(eGFR)>45 mL/min per 1.73 ㎡,and 24-hour proteinuria level of 0.5-3.0 g,were recruited in 41 hospitals across 19 provinces in China and were randomly divided into five groups:SYKFT,losartan potassium 50 mg or 100 mg,SYKFT plus losartan potassium 50 mg or 100 mg.Main outcome measu res:The primary outcome was change in the 24-hour proteinuria level,after 48 weeks of treatment.Results:A total of 735 participants were enrolled.The percent decline of urine protein quantification in the SYKFT group after 48 weeks was 8.78%±2.56%(P=0.006)more than that in the losartan 50 mg group,which was 0.51%±2.54%(P=1.000)less than that in the losartan 100 mg group.Compared with the losartan potassium 50 mg group,the SYKFT plus losartan potassium 50 mg group had a 13.39%±2.49%(P<0.001)greater reduction in urine protein level.Compared with the losartan potassium 100 mg group,the SYKFT plus losartan potassium 100 mg group had a 9.77%±2.52%(P=0.001)greater reduction in urine protein.With a superiority threshold of 15%,neither was statistically significant.eGFR,serum creatinine and serum albumin from the baseline did not change statistically significant.The average change in TCM syndrome score between the patients who took SYKFT(-3.00[-6.00,-2.00])and who did not take SYKFT(-2.00[-5.00,0])was statistically significant(P=0.003).No obvious adverse reactions were observed in any group.Conclusion:SYKFT decreased the proteinuria and improved the TCM syndrome scores of prima

关键词： Herbal medicine,Chinese Shenyankangfu Tablet Primary glomerulonephritis Randomized controlled trial double blind double dummy

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Decrease of 25 kD protein component in the muscle of myasthenia gravis

引用

中国临床神经科学 2000年第Z1期8卷 87-页

作者： Hui-Min Ren Zhi-Gang ZHOU Xiang-jun Chen Jun Huang Chuan-Zhcn Lu Institute of Neurology Shanghai Medical University.Shanghai 200040 Institute of Neurology Shanghai Medical University. Shanghai 200040

Objective To explore whether the protein components have difference between normal and myasthenia gravis (MG) skeletal muscles and the differential components of protein was associated with muscle contraction components. Methods Proteins were extracted from 10 cases of normal muscles and 17 cases of MG skeletal muscles with PBS and Gubstraub solution, respectively. The components of protein were analyzed by SDS-PAGE in common and micro methods in double blind. Composition of the differential protein band was discovered by two-dimensional electrophoresis. Results SDS-PAGE patterns showed that concentration of the protein band with mass of about 25 kD in the MG muscles were much lower than that in the normal muscles. The density of the protein band in the PBS extraction, in the common method, was 4.20±2.31 and 1.40±0.47 in the normal and MG muscles, respectively (p＜0.01), in the micro method, it was 4.62±1.94 and 1.66±0.56 in the normal and MG muscles. respectively (p＜0.001). The value of density for 25 kD protein band in the Gubstraub solution extraction, in the common analysis was 4.14 ± 1.33 and 2.02 ±1.08 in the normal and MG muscles, respectively (p＜0.001), and it in the micro analysis was 4.26±2.58 and l.34±0.79 in the normal and MG muscles, respectively (p＜0.001).The pattern of two-dimensional electrophoresis demonstrated that the differential 25 kD protein band consisted of two components at least with adjacent isoelectric point on the alkaline side in the gel, and they were proved to be irrelated to the components of myosin light chains. Conclusion It was suggested that 25 kD protein from skcletal muscle could be associated with the pathogeny or developing of MG.

关键词： skeletal muscles differential protein muscle contraction myasthenia gravis isoelectric point double blind

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：